Combining intramuscular and intranasal homologous prime-boost with a chimpanzee adenovirus-based COVID-19 vaccine elicits potent humoral and cellular immune responses in mice근육내 및 비강내 상동 프라임-부스트를 침팬지 아데노바이러스 기반 COVID-19 백신과 결합하면 마우스에서 강력한 체액성 및 세포성 면역 반응을 이끌어냅니다.Article Published on 2022-12-012022-09-11 Journal: Emerging Microbes & Infections [Category] [DOI] 10.1080/22221751.2022.2097479 PMC 바로가기 [Article Type] Article
Immunogenicity and safety of BNT162b2 mRNA vaccine in Chinese adults: A phase 2 randomised clinical trialArticle Published on 2022-12-012022-10-06 Journal: The Lancet Regional Health - Western Pacific [Category] [DOI] 10.1016/j.lanwpc.2022.100586 PMC 바로가기 [Article Type] Article
COVID-19 intranasal vaccines: current progress, advantages, prospects, and challengesCOVID-19 비강내 백신: 현재 진행 상황, 이점, 전망 및 과제Review Published on 2022-11-302022-09-12 Journal: Human vaccines & immunotherapeutics [Category] [DOI] 10.1080/21645515.2022.2045853 PMC 바로가기 [Article Type] Review
Intranasal nanoemulsion adjuvanted S-2P vaccine demonstrates protection in hamsters and induces systemic, cell-mediated and mucosal immunity in miceArticle Published on 2022-11-022022-11-15 Journal: PLoS ONE [Category] [DOI] 10.1371/journal.pone.0272594 PMC 바로가기
Breakthrough COVID-19 cases despite prophylaxis with 150 mg of tixagevimab and 150 mg of cilgavimab in kidney transplant recipientsArticle Published on 2022-11-012022-11-15 Journal: American journal of transplantation : official jou [Category] [DOI] 10.1111/ajt.17121 PMC 바로가기
Safety and immunogenicity of intradermal administration of fractional dose CoronaVac®, ChAdOx1 nCoV-19 and BNT162b2 as primary series vaccinationArticle Published on 2022-10-042022-11-15 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2022.1010835 PMC 바로가기
Safety and immunogenicity of 3 doses of BNT162b2 and CoronaVac in children and adults with inborn errors of immunityArticle Published on 2022-09-202022-11-15 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2022.982155 PMC 바로가기
Intranasal administration of a single dose of MVA-based vaccine candidates against COVID-19 induced local and systemic immune responses and protects mice from a lethal SARS-CoV-2 infectionArticle Published on 2022-09-122022-11-15 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2022.995235 PMC 바로가기
Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trialClinical Trial Published on 2022-08-102022-10-06 Journal: The Lancet. Infectious Diseases [Category] [DOI] 10.1016/S1473-3099(22)00420-0 PMC 바로가기 [Article Type] Clinical Trial
The effect of needle length and skin to deltoid muscle distance in adults receiving an mRNA COVID-19 vaccinemRNA COVID-19 백신을 접종받는 성인에서 바늘 길이와 피부에서 삼각근까지의 거리가 미치는 영향Observational Study Published on 2022-08-052022-09-12 Journal: Vaccine [Category] [DOI] 10.1016/j.vaccine.2022.06.070 PMC 바로가기 [Article Type] Observational Study